Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2157-9024
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma ; volume:7 ; number:1 ; day:24 ; month:1 ; year:2018 ; pages:1-12 ; date:1.2018
Oncogenesis ; 7, Heft 1 (24.1.2018), 1-12, 1.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Sato, Hiroki
- Beteiligte Personen und Organisationen
-
Sakaguchi, Masakiyo
Yamamoto, Hiromasa
Tomida, Shuta
Aoe, Keisuke
Shien, Kazuhiko
Yoshioka, Takahiro
Namba, Kei
Torigoe, Hidejiro
Soh, Junichi
Tsukuda, Kazunori
Tao, Hiroyuki
Okabe, Kazunori
Miyoshi, Shinichiro
Pass, Harvey I.
Toyooka, Shinichi
SpringerLink (Online service)
- DOI
-
10.1038/s41389-017-0017-3
- URN
-
urn:nbn:de:1111-201804134593
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sato, Hiroki
- Sakaguchi, Masakiyo
- Yamamoto, Hiromasa
- Tomida, Shuta
- Aoe, Keisuke
- Shien, Kazuhiko
- Yoshioka, Takahiro
- Namba, Kei
- Torigoe, Hidejiro
- Soh, Junichi
- Tsukuda, Kazunori
- Tao, Hiroyuki
- Okabe, Kazunori
- Miyoshi, Shinichiro
- Pass, Harvey I.
- Toyooka, Shinichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Management of malignant pleural mesothelioma—part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition